Tiazac and transient ischaemic attack Patient Reports February 11, 2012
Tiazac Side Effects Report #6012877-7
Tiazac side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2008. Female patient, 81 years of age, was diagnosed with hypertension and was treated with Tiazac. After drug was administered, patient experienced the following side effects: muscle spasms, restless legs syndrome, transient ischaemic attack. Tiazac dosage: 240 MG (240 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DYAZIDE, CRESTOR. Patient was hospitalized. Patient recovered.
Tiazac Side Effects Report #6043333-8
Tiazac side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 12, 2009. Female patient, 81 years of age, was diagnosed with hypertension, blood cholesterol increased and was treated with Tiazac. After drug was administered, patient experienced the following side effects: blood cholesterol increased, restless legs syndrome, transient ischaemic attack. Tiazac dosage: 240 MG (240 MG, 1 IN 1 D, ORAL. During the same period patient was treated with CRESTOR, DYAZIDE, VYTORIN. Patient was hospitalized. Patient recovered.
Tiazac Side Effects Report #5097768-0
Tiazac side effect was reported by a Health Professional from CANADA on Aug 23, 2006. Female patient, 49 years of age, was treated with Tiazac. After drug was administered, patient experienced the following side effects: atrioventricular block first degree, blood pressure decreased, fatigue, oedema peripheral, pulmonary congestion, transient ischaemic attack. Tiazac dosage: 360 MG QD PO. During the same period patient was treated with PERINDOPRIL ERBUMINE. Patient recovered.
Tiazac Side Effects Report #5444114-6
Tiazac side effect was reported by a Health Professional from CANADA on Aug 17, 2007. Female patient, 49 years of age, was treated with Tiazac. After drug was administered, patient experienced the following side effects: atrioventricular block first degree, blood pressure decreased, fatigue, joint swelling, oedema peripheral, pulmonary congestion, transient ischaemic attack. Tiazac dosage: unknown. During the same period patient was treated with PERINDOPRIL ERBUMINE. Patient recovered.
Tiazac and transient ischaemic attack 